Reuters is citing documents released as part of a lawsuit by plaintiffs claiming that the product can be linked to ovarian cancer. The New Brunswick, N.J., company has battled in court against such claims and on Friday called the Reuters report “one-sided, false and inflammatory.”

Source: Los Angeles Times December 14, 2018 19:41 UTC